Stem definition | Drug id | CAS RN |
---|---|---|
4138 | 548-62-9 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D000891 | Anti-Infective Agents, Local |
CHEBI has role | CHEBI:33282 | bactericides |
CHEBI has role | CHEBI:35443 | anthelmintics |
CHEBI has role | CHEBI:35718 | antifungal agents |
CHEBI has role | CHEBI:48218 | antiseptics |
CHEBI has role | CHEBI:77178 | biological stain |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Candidal vulvovaginitis | indication | 72605008 | DOID:2272 |
Candidiasis of skin | off-label use | 49883006 | |
Vaginal irritation | contraindication | 161816004 | |
Aphthous ulcer of mouth | contraindication | 426965005 | DOID:9663 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 6.58 | Basic |
pKa2 | 6.08 | Basic |
pKa3 | 5.61 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Mu-type opioid receptor | GPCR | Ki | 6.06 | DRUG MATRIX | |||||
D(1A) dopamine receptor | GPCR | Ki | 5.81 | DRUG MATRIX | |||||
D(2) dopamine receptor | GPCR | Ki | 5.98 | DRUG MATRIX | |||||
Adenosine receptor A2a | GPCR | Ki | 5.72 | DRUG MATRIX | |||||
Alpha-2A adrenergic receptor | GPCR | Ki | 6.70 | DRUG MATRIX | |||||
Cytochrome P450 3A4 | Enzyme | IC50 | 5.44 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2A | GPCR | Ki | 6.12 | DRUG MATRIX | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 6.24 | DRUG MATRIX | |||||
D(3) dopamine receptor | GPCR | Ki | 6.55 | DRUG MATRIX | |||||
Histamine H2 receptor | GPCR | Ki | 5.95 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M1 | GPCR | Ki | 6.58 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M2 | GPCR | Ki | 6.29 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M3 | GPCR | Ki | 6.04 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M4 | GPCR | Ki | 6.85 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M5 | GPCR | Ki | 6.42 | DRUG MATRIX | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 6.56 | DRUG MATRIX | |||||
Sodium-dependent dopamine transporter | Transporter | Ki | 5.49 | DRUG MATRIX | |||||
Cytochrome P450 2D6 | Enzyme | IC50 | 6.08 | DRUG MATRIX | |||||
Adenosine receptor A3 | GPCR | Ki | 5.63 | DRUG MATRIX | |||||
Alpha-1D adrenergic receptor | GPCR | Ki | 6.01 | DRUG MATRIX | |||||
Kappa-type opioid receptor | GPCR | Ki | 6.21 | DRUG MATRIX | |||||
Acetylcholinesterase | Enzyme | IC50 | 5.23 | DRUG MATRIX | |||||
Epidermal growth factor receptor | Kinase | IC50 | 6.33 | DRUG MATRIX | |||||
Tyrosine-protein kinase Fyn | Kinase | IC50 | 5.67 | DRUG MATRIX | |||||
Substance-K receptor | GPCR | Ki | 6.25 | DRUG MATRIX | |||||
Androgen receptor | Transcription factor | Ki | 5.43 | DRUG MATRIX | |||||
Alpha-1B adrenergic receptor | GPCR | Ki | 5.70 | DRUG MATRIX |
ID | Source |
---|---|
4018858 | VUID |
N0000147160 | NUI |
4018858 | VANDF |
C0017440 | UMLSCUI |
CHEBI:41688 | CHEBI |
CVI | PDB_CHEM_ID |
CHEMBL64894 | ChEMBL_ID |
D005840 | MESH_DESCRIPTOR_UI |
113 | INN_ID |
J4Z741D6O5 | UNII |
11057 | PUBCHEM_CID |
4778 | RXNORM |
4780 | MMSL |
4822 | MMSL |
002617 | NDDF |
002912 | NDDF |
387239001 | SNOMEDCT_US |
42638008 | SNOMEDCT_US |
DB00406 | DRUGBANK_ID |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Humco Gentian Violet 1% | HUMAN OTC DRUG LABEL | 1 | 0395-1003 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 12 sections |
Humco Gentian Violet 1% | HUMAN OTC DRUG LABEL | 1 | 0395-1003 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 12 sections |
Humco Gentian Violet 2% | HUMAN OTC DRUG LABEL | 1 | 0395-1005 | LIQUID | 20 mg | TOPICAL | OTC monograph not final | 12 sections |
Humco Gentian Violet 2% | HUMAN OTC DRUG LABEL | 1 | 0395-1005 | LIQUID | 20 mg | TOPICAL | OTC monograph not final | 12 sections |
Gentian Violet 1% | HUMAN OTC DRUG LABEL | 1 | 0395-9114 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 12 sections |
DE LA CRUZ GENTIAN VIOLET | HUMAN OTC DRUG LABEL | 1 | 24286-1531 | TINCTURE | 1 g | TOPICAL | OTC monograph not final | 15 sections |
DE LA CRUZ GENTIAN VIOLET | HUMAN OTC DRUG LABEL | 1 | 24286-1531 | TINCTURE | 1 g | TOPICAL | OTC monograph not final | 15 sections |
DE LA CRUZ GENTIAN VIOLET | HUMAN OTC DRUG LABEL | 1 | 24286-1531 | TINCTURE | 1 g | TOPICAL | OTC monograph not final | 15 sections |
GNP Gentian Violet 1% | HUMAN OTC DRUG LABEL | 1 | 24385-003 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 12 sections |
GNP Gentian Violet 1% | HUMAN OTC DRUG LABEL | 1 | 24385-003 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 12 sections |
Gentian Violet 2% | HUMAN OTC DRUG LABEL | 1 | 54633-014 | SOLUTION | 2 g | TOPICAL | OTC monograph not final | 12 sections |
Gentian Violet 2% | HUMAN OTC DRUG LABEL | 1 | 54633-014 | SOLUTION | 2 g | TOPICAL | OTC monograph not final | 12 sections |
Perineze Triple Dye | HUMAN OTC DRUG LABEL | 3 | 55739-1022 | SOLUTION | 2.29 mg | TOPICAL | OTC monograph not final | 10 sections |
El Valle Gentian Violet | HUMAN OTC DRUG LABEL | 1 | 55758-373 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 13 sections |
Gentian Violet Topical Solution | HUMAN OTC DRUG LABEL | 1 | 65055-401 | LIQUID | 1 g | TOPICAL | OTC monograph not final | 11 sections |
Kerr 100 Triple Dye Dispos-A | HUMAN OTC DRUG LABEL | 3 | 66689-710 | SWAB | 2.20 mg | TOPICAL | OTC MONOGRAPH NOT FINAL | 11 sections |
Kerr 100 Triple Dye Dispos-A | HUMAN OTC DRUG LABEL | 3 | 66689-710 | SWAB | 2.20 mg | TOPICAL | OTC MONOGRAPH NOT FINAL | 11 sections |
Gentian Violet | HUMAN OTC DRUG LABEL | 1 | 73386-140 | LIQUID | 0.10 g | TOPICAL | OTC monograph not final | 7 sections |
Gentian VioletAnti-Infective | HUMAN OTC DRUG LABEL | 1 | 73635-1219 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 11 sections |
Gentian VioletAnti-Infective | HUMAN OTC DRUG LABEL | 1 | 73635-1219 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 11 sections |
Gentian Violet 1% | HUMAN OTC DRUG LABEL | 1 | 82645-917 | LIQUID | 10 mg | TOPICAL | OTC monograph not final | 12 sections |